PropertyValue
?:abstract
  • COVID-19 patients can recover with a median SARS-CoV-2 clearance of 20 days post initial symptoms (PIS) However, we observed some COVID-19 patients with existing SARS-CoV-2 for more than 50 days PIS This study aimed to investigate the cause of viral clearance delay and the infectivity in these patients Demographic data and clinical characteristics of 22 long-term COVID-19 patients were collected The median age of the studied cohort was 59 83 ± 12 94 years All patients were clinically cured after long-term SARS-CoV-2 infection ranging from 53 to 112 days PIS Peripheral lymphocytes counts were normal The ratios of interferon gamma (IFN-γ)-secreting cells to total CD4(+) and CD8(+) cells were normal as 24 68% ± 9 60% and 66 41% ± 14 87% respectively However, the number of IFN-γ-secreting NK cells diminished (58 03% ± 11 78%) All patients presented detectable IgG, which positively correlated with mild neutralizing activity (Mean value neutralisation antibodies titers = 157 2, P = 0 05) No SARS-CoV-2 virus was isolated in Vero E6 cells inoculated with nasopharyngeal swab samples from all patients 50 days PIS, and the cytopathic effect was lacking But one sample was positive for SARS-CoV-2 nucleic acid test in cell supernatants after two passages Genome sequencing revealed that only three synonymous variants were identified in spike protein coding regions In conclusion, decreased IFN-γ production by NK cells and low neutralizing antibodies might favor SARS-CoV-2 long-term existence Further, low viral load and weak viral pathogenicity were observed in COVID-19 patients with long-term SARS-CoV-2 infection
is ?:annotates of
?:creator
?:journal
  • Virol_Sin
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Long-Term Existence of SARS-CoV-2 in COVID-19 Patients: Host Immunity, Viral Virulence, and Transmissibility
?:type
?:who_covidence_id
  • #911957
?:year
  • 2020

Metadata

Anon_0  
expand all